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Summary
There is evidence that a number of medical conditions and co-morbidities are associ-
ated with obesity in young children. This review explored whether there is evidence
of associations with other conditions or co-morbidities. Observational studies of
young children (mean age < 10 years) were identified using electronic searches of five
databases (MEDLINE, Embase, CINAHL, AMED and SPORTDiscus). Of 27 028 stud-
ies screened, 41 (comprising 44 comparisons) met the inclusion criteria. These studies
provided data on five distinct diseases/conditions: asthma (n = 16), vitamin D defi-
ciency (n = 10), iron deficiency (n = 10), allergies (n = 4) and flat-footedness (n = 4).
Thirty-two studies were appropriate for meta-analysis using random-effects models,
and revealed obesity was significantly associated with having asthma (OR 1.5, 95%
CI 1.3–1.7), vitamin D deficiency (OR 1.9, 95% CI 1.4–2.5) and iron deficiency
(OR 2.1, 95% CI 1.4–3.2). Heterogeneity (I2) ranged from 57% to 61%. Narrative syn-
thesis was conducted for all studies. There was no evidence of a consistent associa-
tion between obesity in young children and eczema, dermatitis or rhinitis due to the
low number of studies. However, there was an association with flat-footedness.
These results have implications for health policy and practice and families. Further
research leading to a greater understanding of the associations identified in this
review is suggested.
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1 | INTRODUCTION
While having obesity in childhood is a known predictor of numerous
health conditions in adulthood, 1,2 a growing evidence base has dem-
onstrated the adverse health effects obesity has during childhood and
adolescence. Specifically, an abundance of research has demonstrated
the link between having childhood obesity and cardio-metabolic
disease markers such as high cholesterol, hypertension and abnormal
glucose tolerance, with children with obesity at a threefold increased
risk of hypertension than children without obesity for example.3–5 A
recent systematic review of observational studies and randomized tri-
als demonstrated that 5- to 15-year-old children with obesity had
7.49 mmHg higher systolic blood pressure, 0.15 mmol L−1 higher total
cholesterol, 0.26 mmol L−1 higher triglycerides and significantly higher
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fasting insulin and insulin resistance than children without obesity. 6
The latter finding further supports recent research demonstrating the
association between having childhood obesity and the development
of type 2 diabetes in youth.7
While the relationship between having childhood obesity and
cardio-metabolic risk factors has been well established by published
research, including several systematic reviews, the potential relation-
ship between having obesity in childhood and other co-morbid condi-
tions is not as clearly understood. Furthermore, a focus on these co-
morbidities in younger children with obesity is limited to date. Epide-
miological research has demonstrated associations between childhood
obesity and increased risk of asthma, sleep apnoea, vitamin D
deficiency, non-alcoholic fatty liver disease, dental caries, eye
disorders, atopic disease and musculoskeletal complaints among other
conditions.8–16 However, recent systematic reviews investigating the
health impacts of having childhood obesity have not been definitive
regarding these conditions. Specifically, asthma has increasingly been
linked to having childhood obesity; however, a review by Pulgaron
identified a number of studies in which no association between
childhood obesity and asthma was reported.17 Another systematic
review and meta-analysis of 48 epidemiological studies demonstrated
a weak but significant link between asthma and overweight/obesity in
children. 18 However, a systematic review of 10 longitudinal studies
demonstrated that children who had obesity as a child were more
likely to suffer from asthma either in childhood or in adolescence,19 a
finding supported by an umbrella review of risk factors for
childhood obesity.20
There are a number of plausible explanations for the equivocal
findings observed for the relationship between having some co mor-
bidities and childhood obesity. However, one issue that is rarely dis-
cussed sufficiently in the literature is the methodological issues that
may arise from the practice of combining children with overweight
and obesity during participant recruitment and subsequent analyses.
Many observational studies grouped children with obesity and over-
weight as a combined exposure variable, instead of considering both
conditions as two distinct groups. Participants with overweight and
obesity would rarely be combined in adult studies of co-morbidities
but are routinely combined in paediatric studies. Possible reasons for
this may be that there is relatively low prevalence of children with
obesity in some populations historically, in comparison with over-
weight; therefore, recruiting an adequately powered sample to mea-
sure the outcomes of interest may be more difficult if the inclusion
criteria are limited to individuals with obesity. While overweight with-
out obesity in childhood is associated with numerous health condi-
tions, 21 the grouping of participants with overweight and obesity
together without appropriate stratification or subgroup analysis may
dilute the real relationship between true obesity and the outcome of
interest, which in some cases is considerably more pronounced than
the effects of having overweight alone.6,22 Such issues are evident
from studies that have stratified by body mass index (BMI) percentile,
where the risk of co-morbidity rises as BMI increases, or prevalence is
higher in groups with obesity compared with groups with overweight
as defined by standardized cut-offs.11,22
Another potential source of inconsistent findings in research on
the co-morbidities of child and adolescent obesity may be the numer-
ous different age ranges used to define ‘childhood’ among the publi-
shed literature. While some studies will distinguish childhood from
adolescence using either internationally recognized categories, or
researcher-defined cut-offs, others will take an all-encompassing
approach and group all participants together from early childhood up
to late adolescence. An issue with this approach is that the physiologi-
cal, behavioural and metabolic differences between a young child and
an older adolescent may have a significant influence on the outcome
of interest. 23
The aim of this current systematic review was therefore to
update and synthesize the evidence base on the physical co-
morbidities of childhood obesity, focusing specifically on the impact
of obesity (rather than overweight) in children under 10 years old and
excluding co-morbidities of childhood obesity that have been well-
established by previous systematic reviews and meta-analyses.
2 | METHODS
This systematic review was prospectively registered with PROSPERO-
registration number: CRD42018079387. The Preferred Reporting
Items for Systematic reviews and Meta-analyses (PRISMA) checklist
was used to inform the conduct and reporting of this review. The
methods used were guided by two expert Cochrane reviewers
(AM and CS).
2.1 | Inclusion and exclusion criteria
Observational studies of a cross-sectional, longitudinal or case–
control design were included if they reported one measure of adipos-
ity (e.g., BMI) in childhood (WHO definition; ≤9.9 years) and measured
at least one physical health outcome in either childhood or adoles-
cence (age 0–19 years). Studies that included children older than
10 years of age were included if the mean age of the overall sample
was ≤9.9 years. Therefore, the overall age range of children within the
included studies was 2–19 years (a number of studies stratified by age
groups). Included studies were required to contain both groups
with obesity and groups without obesity as a comparison within
the sample and be published in English. Studies were also required
to include both children with and without the respective co-morbid
conditions. Studies that only recruited children with co-morbidities
were excluded.
A number of co-morbid conditions including cardiovascular dis-
ease markers, diabetes, dental carries, sleep apnoea and metabolic
syndrome were not incorporated into the search strategy for this
review as the relationship is either well established, or a recent good-
quality systematic review has been published relating to these
conditions.24–26 Therefore, any studies reporting exclusively on these
outcomes concerning childhood obesity were excluded. However, all
other potential co-morbidities of childhood obesity were deemed
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eligible for inclusion in the review providing they met the inclusion
criteria. Studies were excluded if
• The study population had a prior health condition that would limit
generalizability of the study findings (such as children born preterm
or who had a disability).
• Studies that exclusively recruited children who had the outcome of
interest (co-morbidity) without an unaffected comparison group
(as this would not allow for the assessment of weight status on the
incidence of the condition).
• All participants in the study population had the exposure (obesity)
without a comparison group that did not have obesity.
• Reported exclusively non-physical conditions (i.e., mental health
conditions).
• Recognized definitions of obesity were not used or reported in the
study (e.g., ≥95th percentile for age and gender using national or
international growth charts).
• Children with obesity and overweight were combined without
stratification during analysis.
• The mean age of the sample was over 9.9 years at the time of obe-
sity exposure.
• Anthropometry or presence of morbidities was obtained through
parental or self-report (parental reporting of doctor diagnosis of
condition was included).
2.2 | Search strategy and study selection
A computerized search of five electronic bibliographic databases
(MEDLINE, Embase, CINAHL, AMED within Ovid and SPORTDiscus
within Ebsco database platforms) was undertaken from January 2001
to December 2016. A forward citation search was also conducted on
all eligible studies up to December 2018. This allowed for the identifi-
cation of relevant studies that had been published during the time
that had elapsed between the original search and completion of full-
text screening. A comprehensive systematic review was published in
2003 in this subject area5 limiting the need to search databases from
their inception. The search strategy used was checked and approved
by a specialist librarian in addition to an experienced systematic
reviewer (AM) before being executed in two database platforms (Ovid
and EBSCOhost). The search strategy consisted of three categories,
namely, (i) population group, incorporating truncated terms such as
‘child*,’ ‘infan*’ and ‘adolesc*.’ (ii) Exposure, using adiposity-related
terms (e.g., ‘body mass index,’ ‘obes*’ and ‘adipos*). (iii) Outcomes,
where broad headings were initially used (e.g., ‘health,’ ‘comorbid* or
co-morbid*’) before becoming more focused on specific health condi-
tions that were identified as potential co-morbidities of obesity from
the published literature (e.g., ‘pes planus,’ ‘asthma,’ ‘musculoskeletal
diseases’). Where possible, MESH-headings were used in addition to
free-text words to account for databases without the MESH function
and specific conditions not covered under MESH-headings. The
search was restricted to children, human subjects and primary
research studies.
Identified studies were independently screened for eligibility by
two reviewers (SM and JG), initially by title and abstract (a random
20% of identified papers were double-screened), before double full-
text screening was conducted for all papers that were deemed eligible
after title and abstract screening. In addition to the two reviewers dis-
cussing any inconsistencies in identification, where consensus could
not be reached, a third reviewer (JRR) was included in the discussion
to support resolution of the decision. Following full-text screening, eli-
gible studies had their reference lists searched for potentially relevant
studies, as did relevant published systematic reviews. Relevant titles
were exported to an excel spreadsheet and screened using the same
methods as initially applied to the articles identified through database
searches.
2.3 | Quality assessment
The quality of eligible studies was assessed using an adapted version
of the Newcastle–Ottawa scale (NOS) previously used in a review by
Herzog et al.27 The tool has been adapted to assess the quality of
cross-sectional studies in addition to cohort and case–control studies.
The scale assesses studies against the following criteria: (i) selection
of the sample; (ii) comparability of the sample/participants;
(iii) assessment of exposure and outcomes. Stars are awarded for
high-quality aspects of each study against the three aforementioned
criteria, with a total of nine stars available for case–control and cohort
studies and eight stars available for cross-sectional designs. Studies
awarded less than five stars were classed as having a high risk of bias,
while an award of ≥5 stars indicated low risk of bias. The scale has
been specifically designed for non-randomized studies and does not
report summary scores, which have been shown to be unreliable.28
Two researchers independently appraised each study before dis-
cussing any disagreements. No formal overall assessment of the qual-
ity of evidence was undertaken, as this review only included
observational studies, which are deemed by GRADE29 to be of either
low to very low quality of evidence.
2.4 | Data extraction
The following data were extracted from each study: authors, publica-
tion year, study design, study population characteristics (sample size,
geographic location, age ranges, % female), method of recruitment,
exposure (exposure assessment method, the definition of obesity),
outcomes (outcome assessment method, the definition of outcome,
number of outcomes), method of analysis, reported effect estimates
(odds ratios, relative risk, proportions, prevalence and relevant confi-
dence intervals), level of significance reported and confounders con-
trolled for in the analysis. We also planned to collect any data on the
socio-economic status (SES) of children under study, given the known
association between some medical conditions and SES in adults, and
this field was included in our data extraction form. Data were
extracted by two researchers independently using the pre-designed
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form, which was piloted on a random sample of studies prior to full
data extraction commencing.
2.5 | Data synthesis and meta-analysis
Both meta-analysis and narrative synthesis were performed for this
review. Due to the inconsistent nature of information reported in a
number of included studies, coupled with considerable study hetero-
geneity, it was not possible to include all the studies in the meta-ana-
lyses. Where narrative synthesis was adopted, recommendations
outlined in the Cochrane handbook of systematic reviews were
followed,30 whereby the characteristics of each study were summa-
rized in terms of the study design, risk of bias and study context for
each outcome. This was then followed by an exploration of the simi-
larities and differences between each studies' findings.
Random-effects meta-analysis was conducted on three outcomes
in this review: asthma, vitamin D deficiency and iron deficiency. Odds
ratios and corresponding 95% confidence intervals were collated from
studies reporting these results. For studies that did not report odds
ratios, information was collected on the number of children with obe-
sity versus children without obesity, in addition to the number who
presented with the outcome of interest within these two exposure
groups. Pooled odds ratios and 95% confidence intervals were gener-
ated using random-effects method on MetaXL meta-analysis software
(Version 5.3; EpiGear International Pty Ltd). Forest plots were gener-
ated for each outcome, and funnel plots were used to visually assess
publication bias. Heterogeneity and inconsistency were assessed
using Cochran's Q statistical test, with the inconsistency test
(I2 > 50%) used to indicate moderate heterogeneity.
Where a significant proportion of the studies were of high risk of
bias, a sensitivity analysis was conducted to assess whether their
removal from the model significantly affected the overall result. For all
analyses, the level of significance was set at ≤.05.
3 | RESULTS
3.1 | Description of included studies
Of the 27 028 studies identified following database searches and de-
duplication, 41 met the inclusion criteria (Figure 1). These studies
presented results investigating relationships between childhood obe-
sity and five distinct health outcomes: asthma (n = 16),31–45 vitamin D
F IGURE 1 PRISMA flow diagram for
study identification and inclusion
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deficiency (n = 10),46–55 iron deficiency (n = 10),34,56–64 flat-foot-
edness/pes planus (n = 4)65–68 and allergies (n = 4).34,39,69,70 Two
of the studies identified reported results for more than one of
the outcomes.
Although one of the original aims of the review was to investi-
gate obesity in children under <10 years and co-morbidity in later
childhood or adolescence, we did not identify any longitudinal
studies that followed young children into adolescence. Therefore,
all analyses investigated the associations between having obesity
and co-morbid conditions during childhood defined as under
10 years of age.
3.2 | Study characteristics
Study characteristics are summarized in Tables 1–5. The majority of
included studies were cross-sectional studies (n = 29), followed by
case–control studies (n = 8). Four studies were longitudinal, three
being prospective cohort studies, and one a Mendelian randomization
study. Studies varied considerably by sample size, from a case–control
study with 100 participants to a repeat cross-sectional study totalling
36 152 participants. All studies involved the objective measurement
of anthropometry by trained practitioners. All outcomes were objec-
tively measured using established protocols, with the exception of
asthma and allergies, for which the majority of studies employed valid
diagnostic survey methods to obtain confirmation via parental report
of diagnosis by a health professional.
3.3 | Study quality
Overall, cohort studies were rated as having a lower risk of bias than
the case–control studies, with mean NOS scores of 7.4/9 and 6.3/9,
respectively (a higher score equates to a lower risk of bias). Cross-
sectional studies had a mean score of 6.3 out of a possible 8 stars. In
general, studies of all designs did not adequately describe or justify
sample sizes or demonstrate the representativeness of the sample to
the general population. Because of the stringent inclusion criteria
adopted for this review, the included studies all scored highly on the
NOS items pertaining to ‘assessment of exposures and outcomes.’ Six
studies received a rating of below 5 stars (four cross-sectional and
two case–control) and were deemed to have a high risk of bias. The
NOS score and corresponding risk of bias for each study are summa-
rized inTables 1–5.
3.4 | Association between childhood obesity and
asthma
Fifteen studies were grouped comparing the odds of asthma diagnosis
between children with and without obesity.31–45,71 Six studies pres-
ented results separately for different subgroups within the study sam-
ple (i.e., by age group and ethnicity),32,34,38,39,42,44 and these results
are presented separately in the forest plot output (Figure 2). Addition-
ally, subgroup analysis of four studies that presented results sepa-
rately for boys and girls is also included in the forest plot. The meta-
analysis demonstrated that having childhood obesity significantly
increased the odds of asthma diagnosis by over 50% in comparison
with children without obesity (OR 1.5; 95% CI 1.3–1.7). Inconsistency
was moderate (I2 = 57%). In subgroup analysis by sex, boys showed
higher odds than girls for having asthma and obesity (OR 2.0; 95% CI
1.4–2.9 and OR 1.6; 95% CI 1.2–2.2, respectively). However, this
finding was not statistically significant (p > .05). Two of the studies
were assessed as having a high risk of bias.31,33 However, removal of
these studies from the model in a sensitivity analysis did not lead to a
statistically significant change in the pooled result (OR 1.5; 95% CI
1.3–1.7). No publication bias was indicated by the funnel plot
(Figure 3).
One additional study met the inclusion criteria for the review
but was not appropriate for inclusion in the meta-analysis, as it
was a large prospective cohort study,71 which presented time-to-
event analysis that would be poorly interpreted by conversion to
odds. The study was evaluated as having a low risk of bias and
reported that having moderate obesity (≥95th centile) and extreme
obesity (≥99th centile) both significantly increased the risk of
asthma diagnosis.71
3.5 | Association between childhood obesity and
vitamin D deficiency
Nine separate studies were included in the meta-analysis of vitamin D
deficiency and obesity,46–48,50–55 resulting in a pooled odds ratio of
1.9 (95% CI 1.4–2.5) (Figure 4). The studies showed moderate hetero-
geneity (I2 = 58%). The majority of studies defined deficiency as
<20 ng ml−1, and one study reported separate odds ratios for defi-
ciency and severe deficiency, which have been added to the forest
plot separately.50 Studies that reported serum levels in nmol L−1 were
less uniform, with deficiency cut-offs ranging from <17.5 to
<30 nmol L−151,55 (see Table 2). Two of the studies included in the
meta-analysis had a high risk of bias.46,48 When these studies were
removed during sensitivity analysis, the pooled effect size was
reduced to OR 1.7 (95% CI 1.3–2.3).
One additional study49 reported insufficient data to allow for
pooling within the meta-analysis and was judged as having a high risk
of bias.49 This study reported significantly lower vitamin D levels in
children with obesity, due to its small sample size, this study would
not have significantly influenced the overall effect size in pooled anal-
ysis had it been included.
3.6 | Association between childhood obesity and
iron deficiency
Ten studies investigated the relationship between childhood
obesity and iron deficiency34,56–64 of which nine were appropriate
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for meta-analysis (Figure 5). Two of these studies conducted
separate analyses by sex,34,59 with both subgroups included in the
model individually. Meta-analysis revealed that having obesity
doubled the odds of iron deficiency diagnosis (OR 2.1; 95% CI
1.4–3.2). However, the removal of one study56 with a large effect
size during sensitivity analysis reduced the association (OR 1.8;
95% CI 1.3–2.6).
One case–control study60 assessed as having a low risk of bias
was not appropriate for meta-analysis due to insufficient reporting of
data necessary for calculation of odds and found children with obesity
to have significantly different markers of iron deficiency than the
control group. Specifically, children with obesity had significantly
lower iron, transferrin saturation and total-iron binding capacity along
with higher ferritin, soluble transferrin receptors and hepcidin-25 than
children of normal weight.
3.7 | Association between childhood obesity and
pes planus (flat-footedness)
Four studies investigated the relationship between childhood obesity
and having flat-footedness.65–68 Of these, one was a longitudinal
study,65 two were of a cross-sectional design66,67 and one was a case
control study.68 All four studies were of low risk of bias and reported
a statistically significant association between having flat-footedness
and obesity. One study66 investigated both bilateral and unilateral
flat-footedness but only found having obesity to significantly increase
the odds of the bilateral condition (OR 1.9; 95% CI 1.2–2.9), while the
remaining three studies investigated bilateral flat-footedness only. All
four studies were assessed as having a low risk of bias following qual-
ity assessment (Table 4).
3.8 | Association between childhood obesity and
allergies
Four studies assessed the relationship between childhood obesity
and allergic conditions.34,39,69,70 Two distinct conditions were
investigated within the studies; all four studies assessed
eczema/dermatitis, and one study also included rhinitis as an out-
come.39 Additionally, one study reported results from the skin prick
test.70 Three of these studies had a cross-sectional design, and one
was a case–control study.69 All four studies had a low risk of bias
(Table 5). Three of the four studies found having obesity to
increase the odds of eczema/dermatitis diagnosis; however, these
effects were small to moderate.39,69,70 One study reported no
association between eczema and obesity/severe obesity.34 Having
obesity was found to slightly increase the odds of rhinitis diagnosis
in one study (OR 1.3; 95% CI 1.0–1.7) when the sample was
analysed collectively. However, a differential effect by sex was
reported, as the association was only evident in girls and not
boys.39 Obesity was not found to significantly increase the odds of
a positive skin prick test (OR 1.1; 95% CI 0.9–1.4).T
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4 | DISCUSSION
This systematic review and meta-analysis investigated associations
between obesity in young children and multiple co-morbid conditions.
Though this topic has been studied through both primary research
and recent systematic reviews,17,18,72–78 we investigated obesity as a
distinct condition from overweight. This is in contrast to similar
systematic reviews in the subject area, which have included studies
that combine individuals with overweight or obesity, or do not stratify
by weight status in the analysis.17–19,73,78 We also used more strin-
gent inclusion criteria to define childhood as children under 10 years,
potentially offsetting the physiological, cultural and behavioural
effects that later childhood/adolescence can have on obesity co-
morbidities.79,80
F IGURE 2 Forest plot for random effects
meta-analysis of studies investigating
relationships between childhood obesity and
asthma (OR = odds ratio; CI = confidence interval)
F IGURE 3 Funnel plot for studies reporting
on the relationship between obesity and asthma
in Meta-analysis. (ES = effect size)
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The results of our review offer a number of important findings.
Firstly, the meta-analysis of childhood obesity and asthma diagnosis
appears to support previous results from systematic reviews in this
area,18,77,78 while also further distinguishing the effects of having obe-
sity considered explicitly from overweight. Chen et al.77 reported a
significantly higher risk of incident asthma among children and adoles-
cents with obesity compared with children without obesity (relative
risk 2.02; 95% CI 1.16–3.50), while a narrative synthesis by
Papoutsakis et al.18 concluded that there was a clear relationship
between childhood obesity and asthma incidence. Our finding that
having obesity at a young age increased the odds of asthma by over
50% indicates that there is a possible relationship between the two
conditions. However, we did not identify any longitudinal studies that
were appropriate for meta-analysis based on our inclusion criteria,
meaning the cross-sectional data that our findings are based on can-
not offer any indication of a causal link between obesity and asthma.
One cohort study included in our narrative synthesis found that not
only did having a higher BMI predispose children to subsequent
asthma development, but children with both asthma and obesity or
overweight were also more likely to develop a severe asthma pheno-
type than healthy weight children with asthma.71 A meta-analysis of
six longitudinal studies also found that asthma risk increased by 35%
among children with obesity/overweight.78 Conversely, Chen et al.
reported that asthma in fact preceded the onset of obesity even after
controlling for glucocorticosteroid usage, with children with asthma
having 51% higher risk of developing obesity at follow-up than chil-
dren without asthma.81
There may be legitimate physiological and behavioural explana-
tions for both directions of the relationship. Firstly, physiological
consequences of obesity such as reduced lung and tidal volume,
low-grade systemic inflammation and changes in adipose-derived
hormones likely promote the onset of asthma.82 Conversely,
children with normal weight and asthma may be at a higher risk of
developing overweight and obesity due to the observed tendency
for children with asthma to avoid moderate-vigorous physical
activity,83,84 an important protective factor against excess weight
gain.85 Additionally, asthma medications such as glucocorticosteroids
are theorized to promote weight gain through increased lipid
metabolism and storage.81
Of the four identified studies relating to musculoskeletal disor-
ders included in our review, all related to flat-footedness, and all
found having obesity to significantly increase risk. Other musculoskel-
etal disorders have been studied in relation to childhood obesity;
however, these did not meet our inclusion criteria. A recent review by
Paulis and colleagues found musculoskeletal pain to be related to
childhood overweight and obesity,73 supporting the findings of our
review that obesity may have structural/biomechanical consequences.
Potential physiological explanations for this are expressed in the liter-
ature, with excess fat deposits on feet or excess load-bearing due to
excess weight causing arches to collapse in children with obesity.68
F IGURE 4 Forest plot for random effects
meta-analysis of studies investigating
relationships between childhood obesity and
vitamin D deficiency
F IGURE 5 Forest plot for random effects
meta-analysis of studies investigating
relationships between childhood obesity and
iron deficiency
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This review identified vitamin D deficiency as a condition that is
associated with obesity in young children, a finding that has only pre-
viously been investigated in a small number of systematic
reviews.17,74,75 Periera-Santos and colleagues found that obesity in
children and adolescents increased the prevalence of vitamin D defi-
ciency by 37% in a meta-analysis of eight studies.74 Another meta-
analysis reported a pooled odds ratio of 3.43 (95% CI 2.33–5.06).75
Our finding from the present review that having obesity increases the
odds of vitamin D deficiency further supports these findings. How-
ever, as with asthma, the studies that met the inclusion criteria for this
review were all cross-sectional in nature, and therefore, a causal rela-
tionship could not be confirmed. Physiological mechanisms of vitamin
D deficiency as a consequence of obesity have been discussed in the
literature86; however, the nature of the relationship is still poorly
understood. A longitudinal study of Colombian 5–12 year olds found
vitamin D deficient participants had a 0.1/year greater change in BMI
than vitamin D sufficient children,9 indicating that the physiological
effects of obesity such as impaired hydroxylation may contribute to
lower vitamin D levels in children with obesity.87 It is also important
to consider that vitamin D deficiency has been shown to increase
asthma severity, which may indicate each condition may mediate any
relationship with obesity.88 Despite this, few studies included in this
review controlled for this potential confounding (Tables 1 and 2). Fur-
thermore, it is theorized that having obesity may impair the bioavail-
ability of vitamin D for bloodstream absorption, as it is fat-soluble,
and instead stored in adipose tissue reservoirs,89 further highlighting
the complexity of the relationship between the two conditions.
This review also found that childhood obesity increased the odds
of having iron deficiency, which to our knowledge is only the second
such meta-analysis to demonstrate this relationship and the first to do
so exclusively in children aged <10 years.76 An important observation
that applies to both vitamin D and iron deficiency is that they are both
nutritional deficiencies. It could therefore be that causation may be
related to diet quality, as children with obesity have been shown to
have poorer nutritional intake (lower nutrient density, consuming less
iron-rich foods) than children with normal weight in epidemiological
studies.90 A small number of studies included in our review controlled
for diet in their analysis,47,49,58 still finding the conditions to be associ-
ated with obesity. However, the majority of studies concerning vita-
min D and iron status did not include diet/nutrient intake as a
covariate, which may have confounded the results obtained for these
studies. In the case of vitamin D, this can be extended to include time
spent outdoors (or physical activity as a proxy measure of ultraviolet
light exposure), as it has been demonstrated that children with obesity
spend less time in outdoor play and longer periods sedentary
indoors.91 With vitamin D levels mediated by sunlight exposure,47 this
could potentially explain the differences observed in children with
obesity from a behavioural perspective. Therefore, the results of a
number of included studies that did not control for these covariates
should be interpreted with caution.46,48,50–53,55 In the case of iron
deficiency, while mechanisms explaining effects of obesity on the con-
dition are not fully understood, individuals with obesity have both
increased iron requirements (secondary to increased blood volume)
and reduced iron absorption (secondary to increased inflammation).92
Interventions to reduce weight status in children with vitamin D and
iron deficiency would therefore enhance understanding of the causal
effects of having obesity in these conditions.
While the inclusion criteria adopted for this review are a strength
of this study, there are a number of limitations that should be consid-
ered when interpreting the findings. We decided against conducting
an overall assessment of the quality of evidence for each outcome by
using GRADE assessment criteria.29 Despite this, an alternative
assessment of some key quality indicators adds further context to the
strength of the evidence presented in this review. Specifically, the
majority of studies were cross-sectional or case–control studies,
which are more susceptible to bias than longitudinal studies of the
same methodological rigour. Secondly, inconsistency was evident as
the moderate–high heterogeneity observed within the meta-analyses
in this review reflects the fact that a number of included studies did
not adequately control for confounding factors in their analyses. It is
therefore possible that the results of this review may have been
affected by residual confounding and should be interpreted with cau-
tion. Definitive causal effects of childhood obesity on the co-morbid
conditions identified in this review have still to be established, but
plausible mechanisms have been identified as discussed above. It
would therefore be beneficial for behavioural and environmental
obesity treatment interventions to include measurement of morbidity
as an outcome in evaluations, to determine if reductions in weight
status are also accompanied by improvements in disease
symptoms/presentation.
This systematic review and meta-analysis identified a number of
co-morbidities of childhood obesity that were not well established pre-
viously. Evidence of an association between childhood obesity and diag-
nosis of asthma, vitamin D deficiency, flat-footedness and allergies is
reported, in addition to the novel finding that iron deficiency is a poten-
tial co-morbidity of childhood obesity. Additionally, it appears that a bet-
ter understanding of any important inequalities (by SES) in the
relationship between obesity and health conditions in young children is
needed to help support policy and practice with regard to obesity pre-
vention in children.93 Healthcare professionals may find our results help-
ful when treating pediatric patients with obesity, in terms of additional
assessment and consideration for the co-morbid conditions identified
and investigated in this review. The potential for obesity to cause harm
as early as childhood is apparent, and efforts to prevent obesity in the
early years could, in turn, alleviate the health burden of conditions asso-
ciated with having excess weight in childhood.
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